Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.
Cite this article
Time to Treatment and Acute Coronary Syndromes: Bridging the Gap in Rapid Decision Making
1 Department of Emergency Medicine, Cleveland Clinic Foundation, Cleveland OH
Rev. Cardiovasc. Med. 2010, 11(S2), 45–50; https://doi.org/10.3909/ricm11S2S0001
Published: 20 February 2010
The role of cardiac biomarkers in the diagnosis, risk stratification, and treatment of patients with chest pain and suspected acute coronary syndromes (ACS) has continued to evolve. Although it is clear that troponin (Tn) measurement provides independent prognostic information in patients with suspected ACS, it is less well established that early B-type natriuretic peptide (BNP) measurement provides additional incremental prognostic information above and beyond electrocardiography and Tn measurement. It is useful to identify patients at high risk for adverse events through measurement of Tn and BNP levels so that timely treatment decisions can be made.
Acute coronary syndromes
B-type natriuretic peptide